Bluejay Diagnostics (BJDX) Shares Outstanding (2020 - 2026)

Bluejay Diagnostics' Shares Outstanding history runs 7 years deep, the most recent figure standing at $1.0 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 647.07% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.0 million (up 647.07% YoY), while the FY2025 annual figure was $604534.0, up 336.48% from the prior year.
• Shares Outstanding came in at $1.0 million for Q1 2026 at Bluejay Diagnostics, up from $604534.0 in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $1.6 million in Q3 2025 to a low of $774.0 in Q4 2023.
• A 5-year average of $523602.5 and a median of $154893.0 in 2023 frame the typical range for Shares Outstanding.
• On a YoY basis, Shares Outstanding climbed as much as 158321.7% in 2022 and fell as far as 99.75% in 2022.
• Bluejay Diagnostics' Shares Outstanding stood at $2526.0 in 2022, then tumbled by 69.36% to $774.0 in 2023, then soared by 17794.44% to $138503.0 in 2024, then soared by 336.48% to $604534.0 in 2025, then soared by 71.16% to $1.0 million in 2026.
• According to Business Quant data, Shares Outstanding over the past three periods registered $1.0 million, $604534.0, and $1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison